Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC

NCT03998085 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Anlotinib Hydrochloride

Sponsor

The First Hospital of Jilin University

Collaborators

[object Object]